Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The aim of this study was to assess the prevalence and patterns of psychoactive and over-the-counter medicines in a large cohort of individuals with autism. We conducted a mail survey of 3,228 families that are members of the Autism Society of North Carolina. This is one of the largest chapters of the Autism Society of America. The survey form addressed current medicines used, side effects, demographic characteristics, and medical conditions. Some 1,538 member families within the society (48%) responded to the survey. In all, 703 (45.7%) individuals with autism were taking psychotropic drugs, 191 (12.4%) antiepileptic drugs (AEDs), and 86 (5.7%) supplements for autism. The total number taking psychotropic, antiepileptic, or vitamin treatments was 816 (53.1%). Antidepressants (taken by 21.7% of the sample), antipsychotics (16.8%), and stimulants (13.9%) were the most commonly prescribed agents. Univariate and multivariate analyses were conducted to examine factors associated with treatment. Greater age, more severe autism and mental retardation, and more restricted housing were often associated with greater use of psychoactive agents. These findings suggest that individuals with autism are a frequently medicated group, although the empirical research support for most agents being used is still very limited.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite limited research on medications, pharmacological treatment among individuals with ASD has significantly increased in recent years [32].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [32]
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 1×
“…behavioral problems in autism is beginning to emerge; recently, the National Institute of Mental Health Autism Research Units of Pediatric Psychopharmacol-ogy Network reported major symptom reductions in children having both autistic disorder and high levels of irritability (McCracken et al. 2002).”
Self-citationKapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · cited 1×
“The atypicals appear to be an attractive therapeutic option due in part to the lowered risk of developing extrapyramidal symptoms and tardive dyskinesia (Aman and Madrid 1999; Kapur and Seeman 2001).”
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle, C. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110037005 · Cited by 556
Gordon, C. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180039004 · Cited by 390 · cited 1×
“One controlled study of clomipramine indicated that the medicine was effective in reducing both persevera-tive behavior and hyperactivity (Gordon et al. 1993).”
Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation
COOK, E. H., ROWLETT, R., JASELSKIS, C., & LEVENTHAL, B. L. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199207000-00024 · Cited by 272 · cited 1×
“This shift toward the use of SSRIs is in line with a recent body of literature suggesting that they have a role not only for treating depressive symptoms but also for reducing perseverative, stereotypic, and aggressive behaviors (Aman et al. 1999; Cook et al. 1992; McDougle et al. 1996).”
KING, B. H., WRIGHT, D. M., HANDEN, B. L., SIKICH, L., ZIMMERMAN, A. W., MCMAHON, W., CANTWELL, E., DAVANZO, P. A., DOURISH, C. T., DYKENS, E. M., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00010 · Cited by 196 · cited 1×
“One study of amantadine treat-ment in children with autism and high hyper-activity or irritability scores showed equivocal results (no change on parent ratings and significant improvement on clinician ratings; King et al. 2001).”
CODING ORDINAL INDEPENDENT VARIABLES IN MULTIPLE REGRESSION ANALYSES
Walter, S. D., Feinstein, A. R., & Wells, C. K. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114532 · Cited by 172 · cited 1×
“Categorical variables were treated as dummy variables, and where appropriate (e.g., level of mental retardation) were coded in ordinal fashion (Aman et al. 1995; Walter et al. 1987).”
Aman, M. G., Lam, K. S. L., & Collier-Crespin, A. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025883612879 · Cited by 163
Self-citationClinical Effects of Methylphenidate and Thioridazine in Intellectually Subaverage Children
Aman, M. G., MARKS, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199103000-00013 · Cited by 139 · cited 1×
“This relation between level of retardation and stimulant use supports the finding by some researchers that the degree of functional handicap of an individual may influence the probability of achieving a therapeutic response with stimulant drugs (Aman et al. 1991; Handen et al. 1997).”
Self-citationPsychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of Use
Aman, M. G., Bourgondien, M. E. V., WOLFORD, P. L., & Sarphare, G. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199512000-00018 · Cited by 124 · cited 9×
“Although the prevalence rates of certain medication classes (particularly the antidepressants) differed from Aman et al.’s (1995) study, Martin and colleagues observed a similar relation between age and the use of psychotropic medication.”
InfluentialSelf-citation
Research works printed but not linked: 3
- 10.1002/(sici)1098-2779(1999)5:4<253::aid-mrdd2>3.3.co;2-i · doi:10.1002/(sici)1098-2779(1999)5:4<253::aid-mrdd2>3.3.co;2-i
- Kerlinger FN, 2000, Harcourt Inc, 599
- Singh NN, 1998, Paul Brooks, 311
Cited by
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Lam, K. S. L., & Aman, M. G. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0213-z · Cited by 793
“Although this rate of response (32%) was lower than achieved in our previous survey work [Aman, Lam, & Collier-Crespin, 2003 (55% response rate); Langworthy-Lam, Aman, & Van Bourgondien, 2002 (47%)], the current response rate is respectable for a single mailing.”
ResultSelf-citationAutism Spectrum Disorder: Classification, diagnosis and therapy
Sharma, S. R., Gonda, X., & Tarazi, F. I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.007 · Cited by 673
The Lifetime Distribution of the Incremental Societal Costs of Autism
Ganz, M. L. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.4.343 · Cited by 621
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
Metadata
- Authors
- Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E.
- Affiliations
- The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columus, Ohio
- The Ohio State University (US)
- Division TEACCH, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2002-12
- Volume
- 12
- Issue
- 4
- Pages
- 311-321
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2154773963
- Cited by
- 123
- References
- 19
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 10 · 2013: 5 · 2012: 9
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Journal of Child and Adolescent Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ohio State University
- National Institutes of Health (n01mh080011-005)
- National Institute of Mental Health (N01-MH-80011)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, psychotropic drugs, drug use prevalence, antidepressants, antipsychotic drugs, stimulants, antiepileptic drugs, over-the-counter drugs, autism severity, intellectual disability
- MeSH terms
- Adolescent, Analysis of Variance, Autistic Disorder, Child, Child, Preschool, Data Collection, Drug Utilization, Female, Humans, Infant, Male, North Carolina, Psychotropic Drugs, Surveys and Questionnaires, Seizures, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina. https://app.cochat.ai/papers/10.1089/104454602762599853
- The paper
- Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/104454602762599853
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.